These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27091628)

  • 1. α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.
    Guella I; Evans DM; Szu-Tu C; Nosova E; Bortnick SF; ; Goldman JG; Dalrymple-Alford JC; Geurtsen GJ; Litvan I; Ross OA; Middleton LT; Parkkinen L; Farrer MJ
    Ann Neurol; 2016 Jun; 79(6):991-9. PubMed ID: 27091628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.
    Tagliafierro L; Glenn OC; Zamora ME; Beach TG; Woltjer RL; Lutz MW; Chiba-Falek O
    Alzheimers Dement; 2017 Nov; 13(11):1237-1250. PubMed ID: 28431219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies.
    Krohn L; Wu RYJ; Heilbron K; Ruskey JA; Laurent SB; Blauwendraat C; Alam A; Arnulf I; Hu MTM; Dauvilliers Y; Högl B; Toft M; Bjørnarå KA; Stefani A; Holzknecht E; Monaca CC; Abril B; Plazzi G; Antelmi E; Ferini-Strambi L; Young P; Heidbreder A; Cochen De Cock V; Mollenhauer B; Sixel-Döring F; Trenkwalder C; Sonka K; Kemlink D; Figorilli M; Puligheddu M; Dijkstra F; Viaene M; Oertel W; Toffoli M; Gigli GL; Valente M; Gagnon JF; Nalls MA; Singleton AB; ; Desautels A; Montplaisir JY; Cannon P; Ross OA; Boeve BF; Dupré N; Fon EA; Postuma RB; Pihlstrøm L; Rouleau GA; Gan-Or Z
    Ann Neurol; 2020 Apr; 87(4):584-598. PubMed ID: 31976583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Zheng J; Zang Q; Hu F; Wei H; Ma J; Xu Y
    Neurosci Lett; 2019 Jul; 706():146-150. PubMed ID: 31102707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
    Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
    Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease.
    Marsal-García L; Urbizu A; Arnaldo L; Campdelacreu J; Vilas D; Ispierto L; Gascón-Bayarri J; Reñé R; Álvarez R; Beyer K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLB and PDD: a role for mutations in dementia and Parkinson disease genes?
    Meeus B; Verstraeten A; Crosiers D; Engelborghs S; Van den Broeck M; Mattheijssens M; Peeters K; Corsmit E; Elinck E; Pickut B; Vandenberghe R; Cras P; De Deyn PP; Van Broeckhoven C; Theuns J
    Neurobiol Aging; 2012 Mar; 33(3):629.e5-629.e18. PubMed ID: 22118943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.
    Goris A; Williams-Gray CH; Clark GR; Foltynie T; Lewis SJ; Brown J; Ban M; Spillantini MG; Compston A; Burn DJ; Chinnery PF; Barker RA; Sawcer SJ
    Ann Neurol; 2007 Aug; 62(2):145-53. PubMed ID: 17683088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.
    Proukakis C; Shoaee M; Morris J; Brier T; Kara E; Sheerin UM; Charlesworth G; Tolosa E; Houlden H; Wood NW; Schapira AH
    Mov Disord; 2014 Jul; 29(8):1060-4. PubMed ID: 24752924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies.
    Johansen KK; White LR; Sando SB; Aasly JO
    Parkinsonism Relat Disord; 2010 Jun; 16(5):307-15. PubMed ID: 20338799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies.
    Gatt AP; Jones EL; Francis PT; Ballard C; Bateman JM
    Neurosci Lett; 2013 Dec; 557 Pt B():177-80. PubMed ID: 24184878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?
    Markopoulou K; Biernacka JM; Armasu SM; Anderson KJ; Ahlskog JE; Chase BA; Chung SJ; Cunningham JM; Farrer M; Frigerio R; Maraganore DM
    Parkinsonism Relat Disord; 2014 Jun; 20(6):584-9; discussion 584. PubMed ID: 24656894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.
    Tröster AI
    Neuropsychol Rev; 2008 Mar; 18(1):103-19. PubMed ID: 18322801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease.
    Nishioka K; Wider C; Vilariño-Güell C; Soto-Ortolaza AI; Lincoln SJ; Kachergus JM; Jasinska-Myga B; Ross OA; Rajput A; Robinson CA; Ferman TJ; Wszolek ZK; Dickson DW; Farrer MJ
    Arch Neurol; 2010 Aug; 67(8):970-5. PubMed ID: 20697047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease.
    De Marco EV; Tarantino P; Rocca FE; Provenzano G; Civitelli D; De Luca V; Annesi F; Carrideo S; Cirò Candiano IC; Romeo N; Nicoletti G; Marconi R; Novellino F; Morelli M; Quattrone A; Annesi G
    Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):403-7. PubMed ID: 17918232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.